MedPath

VIR-2482

Generic Name
VIR-2482

Study of VIR-2482 in Healthy Volunteers

Phase 1
Completed
Conditions
Influenza A
Interventions
Drug: Placebo
First Posted Date
2019-07-26
Last Posted Date
2022-06-09
Lead Sponsor
Vir Biotechnology, Inc.
Target Recruit Count
100
Registration Number
NCT04033406
Locations
🇦🇺

Investigative Site, Brisbane, Queensland, Australia

© Copyright 2025. All Rights Reserved by MedPath